Renaissance Technologies LLC Takes $4.11 Million Position in HCA Healthcare, Inc. (NYSE:HCA)

Renaissance Technologies LLC purchased a new stake in shares of HCA Healthcare, Inc. (NYSE:HCA) during the 2nd quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor purchased 12,800 shares of the company’s stock, valued at approximately $4,112,000.

Other large investors also recently modified their holdings of the company. Steward Partners Investment Advisory LLC raised its position in shares of HCA Healthcare by 49.0% during the 4th quarter. Steward Partners Investment Advisory LLC now owns 1,993 shares of the company’s stock valued at $539,000 after buying an additional 655 shares in the last quarter. Stifel Financial Corp grew its holdings in shares of HCA Healthcare by 19.8% during the 4th quarter. Stifel Financial Corp now owns 63,429 shares of the company’s stock valued at $17,180,000 after purchasing an additional 10,491 shares during the last quarter. TFO Wealth Partners LLC grew its holdings in shares of HCA Healthcare by 61,450.0% during the 4th quarter. TFO Wealth Partners LLC now owns 1,231 shares of the company’s stock valued at $333,000 after purchasing an additional 1,229 shares during the last quarter. Dorsey & Whitney Trust CO LLC grew its holdings in shares of HCA Healthcare by 21.0% during the 4th quarter. Dorsey & Whitney Trust CO LLC now owns 1,501 shares of the company’s stock valued at $406,000 after purchasing an additional 260 shares during the last quarter. Finally, Bank of Nova Scotia grew its holdings in shares of HCA Healthcare by 56.6% during the 4th quarter. Bank of Nova Scotia now owns 112,796 shares of the company’s stock valued at $30,531,000 after purchasing an additional 40,790 shares during the last quarter. 62.73% of the stock is currently owned by institutional investors.

HCA Healthcare Trading Down 0.1 %

Shares of NYSE:HCA opened at $403.28 on Friday. HCA Healthcare, Inc. has a 52-week low of $215.96 and a 52-week high of $409.42. The stock has a market cap of $105.62 billion, a price-to-earnings ratio of 20.10, a PEG ratio of 1.52 and a beta of 1.67. The company has a quick ratio of 0.94, a current ratio of 1.06 and a debt-to-equity ratio of 27.11. The business has a 50-day moving average price of $378.91 and a 200-day moving average price of $343.05.

HCA Healthcare (NYSE:HCA) last announced its quarterly earnings results on Tuesday, July 23rd. The company reported $5.50 earnings per share for the quarter, beating the consensus estimate of $4.97 by $0.53. The company had revenue of $17.49 billion during the quarter, compared to analysts’ expectations of $17.05 billion. HCA Healthcare had a return on equity of 553.13% and a net margin of 8.40%. HCA Healthcare’s quarterly revenue was up 10.3% on a year-over-year basis. During the same period last year, the business earned $4.29 earnings per share. Equities analysts predict that HCA Healthcare, Inc. will post 22.46 EPS for the current year.

HCA Healthcare Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Monday, September 30th. Investors of record on Monday, September 16th will be given a dividend of $0.66 per share. This represents a $2.64 annualized dividend and a yield of 0.65%. The ex-dividend date is Monday, September 16th. HCA Healthcare’s dividend payout ratio is currently 13.16%.

Analyst Upgrades and Downgrades

A number of equities research analysts have issued reports on HCA shares. StockNews.com raised shares of HCA Healthcare from a “buy” rating to a “strong-buy” rating in a report on Monday, July 1st. Wolfe Research raised shares of HCA Healthcare to a “strong-buy” rating in a report on Thursday, August 29th. Barclays raised their price target on shares of HCA Healthcare from $376.00 to $396.00 and gave the stock an “overweight” rating in a report on Wednesday, July 24th. Leerink Partners raised their price target on shares of HCA Healthcare from $367.00 to $396.00 and gave the stock an “outperform” rating in a report on Wednesday, July 24th. Finally, Truist Financial lifted their target price on shares of HCA Healthcare from $390.00 to $430.00 and gave the company a “buy” rating in a research note on Monday, August 19th. Five equities research analysts have rated the stock with a hold rating, fourteen have assigned a buy rating and three have assigned a strong buy rating to the stock. According to data from MarketBeat.com, HCA Healthcare has a consensus rating of “Moderate Buy” and a consensus target price of $359.89.

Insider Buying and Selling at HCA Healthcare

In other HCA Healthcare news, SVP Kathryn A. Torres sold 1,857 shares of the firm’s stock in a transaction that occurred on Thursday, July 25th. The stock was sold at an average price of $355.05, for a total value of $659,327.85. Following the sale, the senior vice president now directly owns 17,755 shares of the company’s stock, valued at $6,303,912.75. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. In other HCA Healthcare news, SVP Kathryn A. Torres sold 1,857 shares of the firm’s stock in a transaction that occurred on Thursday, July 25th. The stock was sold at an average price of $355.05, for a total value of $659,327.85. Following the sale, the senior vice president now directly owns 17,755 shares of the company’s stock, valued at $6,303,912.75. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, SVP Christopher F. Wyatt sold 4,000 shares of HCA Healthcare stock in a transaction that occurred on Monday, July 29th. The stock was sold at an average price of $360.20, for a total value of $1,440,800.00. Following the completion of the sale, the senior vice president now directly owns 40,449 shares in the company, valued at $14,569,729.80. The disclosure for this sale can be found here. Over the last three months, insiders have sold 17,202 shares of company stock valued at $6,407,273. Company insiders own 1.60% of the company’s stock.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.